HomeRVPH • NASDAQ
add
Reviva Pharmaceuticals Holdings Inc
Previous close
$0.73
Day range
$0.75 - $0.85
Year range
$0.59 - $23.20
Market cap
10.37M USD
Avg Volume
718.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.56M | -43.37% |
Net income | -3.37M | 46.20% |
Net profit margin | — | — |
Earnings per share | -5.19 | -73.00% |
EBITDA | — | — |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.44M | 7.14% |
Total assets | 15.92M | 2.71% |
Total liabilities | 7.28M | -50.47% |
Total equity | 8.65M | — |
Shares outstanding | 12.81M | — |
Price to book | 0.50 | — |
Return on assets | -58.82% | — |
Return on capital | -130.81% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -3.37M | 46.20% |
Cash from operations | -5.80M | 36.29% |
Cash from investing | — | — |
Cash from financing | 7.05M | -58.55% |
Net change in cash | 1.26M | -84.14% |
Free cash flow | -7.20M | -8.47% |
About
Founded
2018
Headquarters
Website
Employees
14
